Perspective
Our work in Perspective
-
Even Concerned Consumers Don’t Know Which Food Choices Have the Lowest Climate Impact
The recommendations of experts aren’t reaching people in the supermarket aisles. So what can be done about it?
Categorized in -
Comments Submitted on HHS Notice of Benefit and Payment Parameters for 2021
Schaeffer Initiative fellows provided comments to HHS on a proposed rule regarding the provision of advance premium tax credits for individuals receiving financial assistance under the ACA.
-
The ACA’s Individual Mandate In Retrospect: What Did It Do, And Where Do We Go From Here?
A USC-Brookings Schaeffer Initiative expert examines if the mandate meaningfully increased coverage and what can be learned from the ACA if policymakers want to achieve universal coverage in the future.
-
Without Oversight, Electronic Prescribing Can Harm Patients
To protect patients from addiction, overdose, and even death, it may be necessary to rein in health information technology — or at least modify it.
Categorized in -
Health Care in President Trump’s Fiscal Year 2021 Budget
Our Schaeffer Initiative experts evaluate the president’s budget in a piece in JAMA Health Forum. The budget includes Medicare provider and drug payment reforms, as well as some policies that will impact the Affordable Care Act.
-
Obesity, Second to Smoking as the Most Preventable Cause of US Deaths, Needs New Approaches
Nearly 40% of Americans are obese, and the numbers are climbing. The U.S. needs to get serious about solutions.
Categorized in -
States Need to Wake up to Public Health Risks From Cannabis
Legalizing cannabis brings states notable benefits, like a boost in tax revenues. But they’ve pushed public health considerations to the sidelines.
Categorized in -
Policy Issues in Dialysis Care
The challenges that policymakers face when trying to encourage the delivery of high quality, cost‐efficient dialysis care to all patients who require dialysis are evident in the state of dialysis care today.
Categorized in -
Remanding Texas v. U.S. to the Lower Court Prolongs Harms to Consumers and the Health Care Industry
How will remanding Texas v. U.S. case to the lower court will affect the health care market? Drug manufacturers face tremendous scientific uncertainty while ACA funding has clearly become a major component in state spending.
-
Provider Charges Relative to Medicare Rates, 2012-2017
Researchers examined data on charges for providers treating Medicare patients and compared them to Medicare’s set payment rate across specialties. They found specialties possessing the ability to surprise bill out-of-network patients higher charges relative to Medicare rates than other specialties.